Ken Griffin Seagen Inc. Transaction History

Citadel Advisors LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $319 Million - $360 Million	1,666,890 Added 218.89%	2,428,418 $515 Million
Q2 2023 Aug 14, 2023	BUY	$187.64 - $206.25 $70.8 Million - $77.9 Million	377,582 Added 98.34%	761,528 $147 Million
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $43.7 Million - $69.6 Million	342,493 Added 826.22%	383,946 $77.7 Million
Q4 2022 Feb 14, 2023	SELL	$117.37 - $139.17 $63.2 Million - $74.9 Million	-538,224 Reduced 92.85%	41,453 $5.33 Million
Q3 2022 Nov 14, 2022	SELL	$135.27 - $180.11 $14.9 Million - $19.9 Million	-110,265 Reduced 15.98%	579,677 $79.3 Million
Q2 2022 Aug 15, 2022	SELL	$108.81 - $179.33 $7.47 Million - $12.3 Million	-68,676 Reduced 9.05%	689,942 $122 Million
Q1 2022 May 16, 2022	SELL	$119.61 - $157.85 $4.63 Million - $6.11 Million	-38,683 Reduced 4.85%	758,618 $109 Million
Q4 2021 Feb 14, 2022	SELL	$142.57 - $190.86 $62.7 Million - $83.9 Million	-439,538 Reduced 35.54%	797,301 $123 Million
Q3 2021 Nov 15, 2021	SELL	$142.45 - $169.82 $7.68 Million - $9.16 Million	-53,939 Reduced 4.18%	1,236,839 $210 Million
Q2 2021 Aug 16, 2021	BUY	$135.08 - $161.1 $143 Million - $170 Million	1,058,266 Added 455.14%	1,290,778 $204 Million
Q1 2021 May 17, 2021	BUY	$137.51 - $190.8 $21.2 Million - $29.4 Million	154,205 Added 196.92%	232,512 $32.3 Million
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $12.9 Million - $16.6 Million	78,307 New	78,307 $13.7 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.